東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/03 | 1,902 | 1,928 | 1,902 | 1,916 | +21 | +1.1% | 77,400 |
2023/03/31 | 1,889 | 1,904 | 1,881 | 1,895 | +11 | +0.6% | 54,800 |
2023/03/30 | 1,889 | 1,900 | 1,879 | 1,884 | -34 | -1.8% | 75,800 |
2023/03/29 | 1,913 | 1,921 | 1,898 | 1,918 | +18 | +0.9% | 118,600 |
2023/03/28 | 1,916 | 1,916 | 1,897 | 1,900 | -4 | -0.2% | 65,800 |
2023/03/27 | 1,890 | 1,904 | 1,880 | 1,904 | +26 | +1.4% | 74,300 |
2023/03/24 | 1,846 | 1,881 | 1,842 | 1,878 | +27 | +1.5% | 78,700 |
2023/03/23 | 1,847 | 1,852 | 1,831 | 1,851 | -8 | -0.4% | 91,100 |
2023/03/22 | 1,872 | 1,875 | 1,851 | 1,859 | +9 | +0.5% | 69,700 |
2023/03/20 | 1,863 | 1,876 | 1,850 | 1,850 | -26 | -1.4% | 65,200 |
2023/03/17 | 1,878 | 1,882 | 1,871 | 1,876 | +11 | +0.6% | 88,700 |
2023/03/16 | 1,850 | 1,870 | 1,838 | 1,865 | -9 | -0.5% | 89,800 |
2023/03/15 | 1,880 | 1,885 | 1,864 | 1,874 | +6 | +0.3% | 102,400 |
2023/03/14 | 1,875 | 1,878 | 1,840 | 1,868 | -26 | -1.4% | 179,100 |
2023/03/13 | 1,908 | 1,911 | 1,881 | 1,894 | -33 | -1.7% | 137,100 |
2023/03/10 | 1,931 | 1,952 | 1,927 | 1,927 | -22 | -1.1% | 133,800 |
2023/03/09 | 1,918 | 1,950 | 1,916 | 1,949 | +37 | +1.9% | 127,400 |
2023/03/08 | 1,906 | 1,919 | 1,892 | 1,912 | +6 | +0.3% | 90,900 |
2023/03/07 | 1,900 | 1,910 | 1,900 | 1,906 | -1 | -0.1% | 62,300 |
2023/03/06 | 1,929 | 1,931 | 1,897 | 1,907 | -9 | -0.5% | 130,700 |
2023/03/03 | 1,885 | 1,916 | 1,880 | 1,916 | +48 | +2.6% | 146,200 |
2023/03/02 | 1,897 | 1,900 | 1,866 | 1,868 | -25 | -1.3% | 161,400 |
2023/03/01 | 1,915 | 1,918 | 1,893 | 1,893 | -22 | -1.1% | 143,000 |
2023/02/28 | 1,929 | 1,931 | 1,914 | 1,915 | -15 | -0.8% | 153,400 |
2023/02/27 | 1,892 | 1,931 | 1,882 | 1,930 | +33 | +1.7% | 211,000 |
2023/02/24 | 1,918 | 1,918 | 1,892 | 1,897 | -14 | -0.7% | 127,800 |
2023/02/22 | 1,915 | 1,920 | 1,898 | 1,911 | -18 | -0.9% | 105,600 |
2023/02/21 | 1,902 | 1,932 | 1,897 | 1,929 | +21 | +1.1% | 112,300 |
2023/02/20 | 1,916 | 1,919 | 1,903 | 1,908 | +6 | +0.3% | 63,700 |
2023/02/17 | 1,919 | 1,922 | 1,902 | 1,902 | -26 | -1.3% | 103,600 |
2023/02/16 | 1,938 | 1,949 | 1,927 | 1,928 | -1 | -0.1% | 74,800 |
2023/02/15 | 1,950 | 1,951 | 1,913 | 1,929 | -13 | -0.7% | 119,300 |
2023/02/14 | 1,950 | 1,951 | 1,904 | 1,942 | -30 | -1.5% | 239,600 |
2023/02/13 | 1,985 | 1,986 | 1,960 | 1,972 | -14 | -0.7% | 98,100 |
2023/02/10 | 1,990 | 2,003 | 1,985 | 1,986 | -9 | -0.5% | 55,100 |
2023/02/09 | 1,998 | 2,013 | 1,991 | 1,995 | -7 | -0.3% | 46,400 |
2023/02/08 | 2,003 | 2,015 | 1,995 | 2,002 | -1 | ±0% | 54,700 |
2023/02/07 | 2,005 | 2,008 | 1,997 | 2,003 | +7 | +0.4% | 24,100 |
2023/02/06 | 1,999 | 2,005 | 1,992 | 1,996 | -3 | -0.2% | 41,100 |
2023/02/03 | 2,003 | 2,011 | 1,987 | 1,999 | -13 | -0.6% | 66,900 |
2023/02/02 | 2,032 | 2,033 | 2,011 | 2,012 | -19 | -0.9% | 56,600 |
2023/02/01 | 2,059 | 2,059 | 2,030 | 2,031 | -17 | -0.8% | 42,100 |
2023/01/31 | 2,033 | 2,054 | 2,031 | 2,048 | +16 | +0.8% | 48,600 |
2023/01/30 | 2,026 | 2,048 | 2,026 | 2,032 | +8 | +0.4% | 56,500 |
2023/01/27 | 2,050 | 2,050 | 2,022 | 2,024 | -16 | -0.8% | 42,800 |
2023/01/26 | 2,040 | 2,045 | 2,029 | 2,040 | -4 | -0.2% | 39,100 |
2023/01/25 | 2,070 | 2,070 | 2,040 | 2,044 | -20 | -1% | 54,500 |
2023/01/24 | 2,061 | 2,075 | 2,055 | 2,064 | +20 | +1% | 46,000 |
2023/01/23 | 2,045 | 2,059 | 2,040 | 2,044 | +6 | +0.3% | 45,100 |
2023/01/20 | 2,023 | 2,040 | 2,020 | 2,038 | +12 | +0.6% | 31,400 |
501~
550
件表示中 / 6935件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 248,500円 | +15.0% | -7.3% | 2.82% | 8.16倍 | 0.77倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
キッセイ薬 | 359,500円 | +14.5% | -2.3% | 2.50% | 13.15倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 225,500円 | - | - | 0.00% | - | 104.45倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 438,000円 | +7.1% | -35.0% | 2.74% | 36.21倍 | 1.01倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 225,200円 | +14.2% | +41.0% | 2.04% | 11.03倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム